Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
Clinical trial NCT05303532 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05303532
- Sponsor
- AstraZeneca
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2026-12-31
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.